Edward Conner

Edward Conner is an accomplished healthcare executive with extensive experience in the biopharmaceutical industry. Currently serving as Chief Medical Officer at Ardelyx, Inc. since August 2025, Conner has previously held the same title at Third Harmonic Bio and has contributed to companies such as Locanabio, Inc. as a Scientific Advisory Board Member, and Imara Inc. as a Board Member. Further leadership roles include serving as Site Lead and Division Head of Gene Therapy Medical & Development at Astellas Gene Therapies, Chief Medical Officer and Senior Vice President at Sangamo Therapeutics, and Vice President at Ultragenyx Pharmaceutical. Conner's earlier career includes positions as Senior Medical Director at BioMarin Pharmaceutical and Medical Director at Genentech, among others. Conner holds a Doctor of Medicine from The Johns Hopkins University School of Medicine, a Doctor of Medicine from the University of Michigan Medical School, and a Bachelor of Science from Duke University.